NEW YORK (GenomeWeb News) — Decode Genetics has netted $18.4 million after selling and leasing back its Chicago-area medicinal chemistry facility, the company said today.
 
The company sold the Woodridge, Ill., facility for $25 million and leased the space back for a 17-year term, Decode said.
 
Decode said it plans to use the cash it made on the deal to fund its drug- and diagnostic-development programs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.